Whartons Jelly Derived Mesenchymal Stem Cells

Wharton s jelly mesenchymal stromal stem cells are harvested from umbilical cord tissue and are considered by many regenerative experts to have the most potential for effective cell based therapy with the added benefit of being far easier and less invasive to retrieve.

Whartons jelly derived mesenchymal stem cells. Wharton s jelly derived mesenchymal stem cells wj mscs have a high proliferation valency and they do not produce teratogen or carcinogen after subsequent transplantation. In a recent study wharton s jelly tissue transplantation has shown to be able to reduce traumatic brain injury and may have therapeutic potential. 2 polish stem cell bank grzybowska 2 41 00 131 warsaw poland. Around 5 million annual births in eu and 131 million worldwide give a unique opportunity to collect lifesaving wharton s jelly derived mesenchymal stem cells wj msc.

Wharton s jelly is therefore a potential source of adult stem cells often collected from cord blood. A recent publication in biomed research international has reviewed the study on the potential benefits of wharton s jelly derived mesenchymal stem cells in treating a variety of diseases. Wharton s jelly derived mesenchymal stem cells wj mscs have been introduced as a possible therapy in hypoxic ischemic encephalopathy hie. Evidences that these cells possess therapeutic properties are constantly accumulating.

Thus more research is needed on the isolation and characterization of mesenchymal ste. According to the authors of the review these stem cells can be collected during millions of births each year at the time of delivery.